What tissues compose a fibroadenoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fibroadenoma Composition

A fibroadenoma is a benign breast tumor composed of both stromal (connective tissue) and epithelial (glandular) elements 1.

Tissue Components

The fibroadenoma consists of two distinct tissue types that proliferate together:

  • Stromal component: Connective tissue framework that forms the bulk of the tumor
  • Epithelial component: Glandular tissue derived from the terminal ductal lobular unit 2

This dual composition distinguishes fibroadenomas as fibroepithelial tumors 3. The proliferation involves both the epithelial cells lining the ducts and the surrounding stromal (connective) tissue, originating specifically from the terminal ductal unit of the breast 2.

Clinical Significance of Composition

The epithelial component can exhibit various changes including:

  • Hyperplasia (found in 32.3% of cases) 4
  • Hormone-responsive features with estrogen-sensitive signatures 5
  • Rarely, atypical changes or carcinoma in situ (2.0% of cases) 4

Important caveat: While the epithelial component may occasionally harbor proliferative changes or atypia, the fibroadenoma itself remains a benign entity. The stromal component is what primarily distinguishes it from purely epithelial lesions.

The balanced proliferation of both tissue types is what creates the characteristic appearance on imaging and histology, though distinguishing cellular fibroadenomas from phyllodes tumors (which also contain stromal and epithelial elements) can be challenging 1, 3.

References

Guideline

breast cancer: noninvasive and special situations.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Research

O-glycosylation expression in fibroadenoma.

Preparative biochemistry & biotechnology, 2010

Research

Genetics and genomics of breast fibroadenomas.

Journal of clinical pathology, 2018

Research

Histopathology of fibroadenoma of the breast.

American journal of clinical pathology, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.